SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Synthetic Blood International, Inc. (SYBD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: t.gawarecki who wrote (1)3/2/1999 10:46:00 PM
From: Micro-Selector  Read Replies (1) of 91
 
Tom:

I hadn't heard about the pending financing, but thanks for the information.

Yes, SYBD will need plenty of money for the clinical trials. However, if they line up a contract with a pharmaceutical company interested in manufacturing, marketing or distributing their products after FDA approval, they may have all the financing they need for at least the first phase of the trials (and later phases conditional of course on merit of the products as the trials progress).

Please keep the thread posted if you hear anything further. Any news on the glucose biosensor? (I suspect the financing may be conditional on receipt of this final patent?)

(Nice move up to $0.12 today!)

Regards,
Micro
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News